Cargando…
COVID‐19, varying genetic resistance to viral disease and immune tolerance checkpoints
Coronavirus disease 2019 (COVID‐19) is a zoonosis like most of the great plagues sculpting human history, from smallpox to pandemic influenza and human immunodeficiency virus. When viruses jump into a new species the outcome of infection ranges from asymptomatic to lethal, historically ascribed to “...
Autor principal: | Goodnow, Christopher C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894315/ https://www.ncbi.nlm.nih.gov/pubmed/33113212 http://dx.doi.org/10.1111/imcb.12419 |
Ejemplares similares
-
Varied functions of immune checkpoints during cancer metastasis
por: Safarzadeh, Ali, et al.
Publicado: (2020) -
Immune Checkpoints in Viral Infections
por: Cai, Huiming, et al.
Publicado: (2020) -
On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
por: Gambichler, Thilo, et al.
Publicado: (2020) -
Mechanisms of resistance to immune checkpoint inhibitors
por: Jenkins, Russell W, et al.
Publicado: (2018) -
Mechanism of resistance to immune checkpoint inhibitors
por: Pandey, Manu R., et al.
Publicado: (2019)